Literature DB >> 1691311

Transcriptional regulation of early-response genes during polyomavirus infection.

G M Glenn1, W Eckhart.   

Abstract

Infection of quiescent BALB/c 3T3 cells with polyomavirus leads to the biphasic accumulation of RNA from several early-response genes. The steady-state levels of RNA of c-fos, c-myc, and c-jun were detected at 0 to 1 and 12 to 30 h after infection but not at 6 h postinfection. Infections with mutant viruses suggest that in the context of a virus infection with other tumor (T) antigens present, large T and middle T antigens are dispensable for the effect and small t antigen is important for the regulation, perhaps in conjunction with large T or middle T antigens. These results are in agreement with those of Zullo et al. (Proc. Natl. Acad. Sci. USA 84:1210-1214). We have further found that this regulation occurs in NIH 3T3 cells and primary mouse embryo fibroblasts. DNA synthesis is not required for this effect. Half-lives of c-fos, c-myc, and c-jun were similarly short at both early and late times after infection, as determined by dactinomycin chase. The regulation of expression occurs at the transcriptional level. Nuclear run-on experiments showed increased rates of transcription both early and late after infection. Also, the polyomavirus early region can transactivate the c-fos promoter in transient transfection assays.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691311      PMCID: PMC249379     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Polyoma gene function required for viral DNA synthesis.

Authors:  B Francke; W Eckhart
Journal:  Virology       Date:  1973-09       Impact factor: 3.616

2.  Polyoma large T antigen regulates the integration of viral DNA sequences into the genome of transformed cells.

Authors:  G Della Valle; R G Fenton; C Basilico
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

3.  Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation.

Authors:  D Templeton; W Eckhart
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

4.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

5.  Expression of the large T protein of polyoma virus promotes the establishment in culture of "normal" rodent fibroblast cell lines.

Authors:  M Rassoulzadegan; Z Naghashfar; A Cowie; A Carr; M Grisoni; R Kamen; F Cuzin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.

Authors:  D W Cleveland; M A Lopata; R J MacDonald; N J Cowan; W J Rutter; M W Kirschner
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

7.  Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus.

Authors:  G G Carmichael; T L Benjamin
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

8.  Characterization of polyoma virus T antigen.

Authors:  Y Ito; N Spurr; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

9.  Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.

Authors:  L W Stanton; R Watt; K B Marcu
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

10.  Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein.

Authors:  R Treisman; U Novak; J Favaloro; R Kamen
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

View more
  20 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element.

Authors:  W Yoo; M E Martin; W R Folk
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Induction of c-jun protooncogene expression and transcription factor AP-1 activity by the polyoma virus middle-sized tumor antigen.

Authors:  A Schönthal; S Srinivas; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.

Authors:  K P Mullane; M Ratnofsky; X Culleré; B Schaffhausen
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

5.  Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells.

Authors:  Beata Sadowska; Robert Barrucco; Kamel Khalili; Mahmut Safak
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Cell cycle control of polyomavirus-induced transformation.

Authors:  H H Chen; M M Fluck
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus.

Authors:  I Boldogh; S AbuBakar; C Z Deng; T Albrecht
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Mutations in the VP1 coding region of polyomavirus determine differentiating stage specificity.

Authors:  L Ricci; R Maione; C Passananti; A Felsani; P Amati
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX.

Authors:  G Natoli; M L Avantaggiati; P Chirillo; A Costanzo; M Artini; C Balsano; M Levrero
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.